fda warning bpc-157 unapproved drug safety concerns Federal health advisers are meeting to review a group of controversial chemicals called peptides, which have become a growing wellness trend. FULL STORY ⬇️ Health advisers begin meeting Thursday

Health advisers begin meeting Thursday to review more than a half dozen peptides, unproven substances that have become a growing wellness trend despite little evidence they are safe or effective. Full story FDA advisers back first four of seven unapproved peptides under review for looser rules The Mighty 790 KFGO KFGO FDA Compliance for Peptide Therapy and BPC 157 Holt Law The Food and Drug Administration's committee on compounded drugs broke with agency scientists and voted in favor of adding peptides to the list of substances compounding pharmacies can make. Follow the link Advisers to the FDA back broad access to unapproved peptides, despite agency concerns

SKU: 93233572649 · From vanierexcavation.com